Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease

INTRODUCTION: Low-dose computed tomography (LDCT) is used for screening for lung cancer (LC) in high-risk patients in the United States. The definition of high risk and the impact of frequent false-positive results of low-dose computed tomography remains a challenge. DNA methylation biomarkers are v...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Gunter, Schlegel, Anne, Kottwitz, Denise, König, Thomas, Tetzner, Reimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226366/
https://www.ncbi.nlm.nih.gov/pubmed/27544059
http://dx.doi.org/10.1016/j.jtho.2016.08.123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226366/
https://www.ncbi.nlm.nih.gov/pubmed/27544059
http://dx.doi.org/10.1016/j.jtho.2016.08.123

Ejemplares similares